SLC5A2 and cardiac arrhythmia: In diabetic patients prescribed SGLT2 inhibitors instead of other diabetic medication in addition to metformin, Duran et al. (86) observed beneficial alterations in ventricular repolarisation dispersion, which in turn is associated with the development of cardiac arrhythmias (87).